A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S264-S265
- https://doi.org/10.1016/s0959-8049(01)81473-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: